Orchestra BioMed files 8-K furnishing Q4 2023 investor presentation

Orchestra BioMed Holdings, Inc.

Company furnished investor presentation as Exhibit 99.1 for use at conferences.
Presentation is furnished under Regulation FD and not deemed filed for liability purposes.
CEO David P. Hochman signed the report on November 14, 2023.

item 7.01 item 9.01

Orchestra BioMed Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-117492

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.